Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial…

By A. Möricke, A. Reiter, M. Zimmermann, H. Gadner, M. Stanulla, M. Dördelmann, L. Löning, R. Beier, W. Ludwig, R. Ratei and 17 more. Blood, 2007

619 citations recorded by the source corpus.

Subfields: Neurology, Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/d40ab24e4dce8fc5e978790da1f11cdd4bd00343